On your 2nd link there dated, Dec. 8, 2011 Pharmac
Post# of 30028
The PR was Titled:
"Pharmacyclics to receive up to $975 million, inclusive of an upfront payment of $150 million, as well as development and regulatory milestone payments.
Profits to be shared 50/50 worldwide. Both Pharmacyclics and Janssen to book revenue, Pharmacyclics in the US and Janssen in the rest of the world"
http://ir.pharmacyclics.com/releasedetail.cfm...eid=631854